Nachrichten
19 Januar 2021
Baylis Medical gab heute die Markteinführung und den ersten klinischen Fall des JLL 2-French-Elektrophysiologie-Mikrokatheters in Europa bekannt.
Press Release
01 September 2020
Baylis Medical announced today the first clinical use of the VersaCross Steerable Access Solution, performed at the University of California, San Francisco (UCSF).
Press Release
07 Juli 2020
Baylis Medical, a Canadian medical device company specializing in cardiology and spine, is pleased to announce that it has made a venture arm investment in Epineuron Technologies Inc., a bioelectronic medical company that provides therapy to support patients with peripheral nerve regeneration.
Press Release
22 Juni 2020
A recent study has demonstrated the feasibility of cardiac small vein mapping using Baylis Medical’s EPstar 2F Fixed Electrophysiology Catheter.
Press Release
17 Juni 2020
Manufacturing of much-needed ventilators set to begin.
Press Release
03 Juni 2020
Baylis Medical firmly rejects any and all forms of racial discrimination. As a company, we are built on a foundation of inclusivity, diversity and understanding. These traits are part of what makes us a strong and resilient team.
Press Release